StrokeNet Thrombectomy Endovascular Platform
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1600 participants.
Also called NCT06289985
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,600 participants
- Sponsor
- Registry
-
NCT06289985
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06289985. Randomized; single masking; primary purpose treatment. Start 2025-01-31 (actual); primary completion 2029-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- StrokeNet Thrombectomy Endovascular Platform
- Acronym
- STEP
- Condition
- Ischemic Stroke
- Intervention (Device)
- Endovascular thrombectomy with any FDA-approved category POL or NRY device
- Intervention (Other)
- Medical Management
- Lead sponsor
- Medical University of South Carolina
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator
- University of Cincinnati
- Collaborator
- University of Virginia
- Collaborator
- Berry Consultants
- Collaborator
- University of California, Los Angeles
- Collaborator
- MOUNT SINAI HOSPITAL
- Collaborator
- Cooper Norcross Health
- Collaborator
- University of Pittsburgh Medical Center
- Collaborator
- Stony Brook University
- Collaborator
- University at Buffalo
Record details
- Record id
cardio:ct-nct06289985- Content hash
bf1af23f8e63a56a1cf16eed77884d197b937e9d36bea072c20a7632cee1f01b